The global bone morphogenetic protein market size is expected
to reach over USD 644.6 million by 2024, based on a new report by Grand View
Research, Inc. Increasing incidence of spinal fusion, trauma, and small bone
surgeries coupled with demand for faster bone recovery are the key drivers
affirming growth of BMP market.
Low back pain and spinal disc
dislocation are some of the most common occupational hazards. Over 75% of such
disorders require spinal surgery after noninvasive treatment options are unable
to provide any relief. Minimally invasive surgery, shorter hospital stays, and
fast recovery are common demands observed among patients. BMP has gained high
acceptance among orthopedic surgeons in recent years owing to its ability to
cater above mentioned benefits
Sport-related injuries, growing
geriatric population, and increasing awareness about osteoinduction products as
an alternative to bone grafting are other drivers accentuating market growth.
BMP has reported outstanding results over bone graft, such as lack of donor
morbidity, extensive surgical procedure, higher recovery time, pain &
numbness, and high cost.
Browse full research report on
Bone Morphogenetic
Protein Market: https://www.grandviewresearch.com/industry-analysis/bone-morphogenetic-proteins-market
Further Key Findings From the Study Suggest:
- rhBMP-2 and rhBMP-7 are the commercially available
recombinant BMPs. rhBMP-2 is widely known for its high osteoinductive
property for faster formation of bone and cartilage in bone fusion
procedures
- rhBMP-2 held more than half of the market share in 2015. Key
attributes contributing toward its growth are high acceptance, wide range
of applications, and easier availability in developing countries
- rhBMP-7 on the other hand is expected to witness decline in
market share over the forecast period owing to factors such as limited
usage and discontinuation of OP-1from 2014 by Olympus
- Spinal fusion held the largest share in 2015. Increasing
cases of sport-related spinal injuries, wide range of product
availability, easier usage, and long-term reliability are major factors
for the aforementioned dominance.
- North America held a significant share of over 65.0% in 2015.
High number of orthopedic surgical procedures, and availability of
favorable reimbursement policies are drivers that can be attributed to for
largest share.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/bone-morphogenetic-proteins-market/request/rs1
Grand View Research has segmented the bone morphogenetic protein
market on the basis of type and applications:
Bone Morphogenetic Protein Type Outlook (Market Revenue in USD
Million, 2013 - 2024)
- rhBMP-2
- rhBMP-7
Bone Morphogenetic Protein Application Outlook (Market Revenue in
USD Million, 2013 - 2024)
- Spinal
fusion
- Trauma
- Reconstruction
- Oral
Maxillofacial
Bone Morphogenetic Protein Regional Outlook (Market Revenue in USD
Million, 2013 - 2024)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment